,

(cid:

)

/ SJA¨LANDER, A., BIRGANDER, R., KIVELA¨, A. and BECKMAN, G.

, p

polymorphisms and haplotypes in different ethnic groups. Human Heredity,

,

(cid:

)

/ SJA¨LANDER, A., BIRGANDER, R., HALLMANS, G., CAJANDER, S., LENNER, P., ATHLIN, L., BECKMAN, G. and BECKMAN, L.

, p

polymorphisms and haplotypes in breast cancer. Carcinogenesis,

,

(cid:

)

/ TAIOLI, E., TRACHMAN, J., CHEN, X., TONIOLO, P. and GARTE, S. J.

, A CYP

A

restriction fragment length polymorphism is associated with breast cancer in African(cid:

)American women. / Cancer Research,

,

(cid:

)

/ TAIOLI, E., MARI, D., FRANCESCHI, C., BONAFE`, M., MONTI, D., BERTOLINI, S., MARINELLI, D. and GARTE, S.

, Polymorphisms of drug-metabolizing enzymes in healthy nonagenarians and centenarians: difference at GSTT

locus. Biochemical and Biophysical Research Communications,

,

(cid:

)

/ THOMAS, M., KALITA, A., LABRECQUE, S., PIM, D., BANKS, L. and MATLASHEWSKI, G.

, Two polymorphic variants of wild-type p

differ biochemically and biologically. Molecular and Cellular Biology,

,

(cid:

)

/ VINEIS, P., VEGLIA, F., BENHAMOU, S., BUTKIEWICZ, D., CASCORBI, I., CLAPPER, M. L., DOLZAN, V., HAUGEN, A., HIRVONEN, A., INGELMAN-SUNDBERG, M., KIHARA, M., KIYOHARA, C., KREMERS, P., LE MARCHAND, L., OHSHIMA, S., PASTORELLI, R., RANNUG, A., ROMKES, M., SCHOKET, B., SHIELDS, P., STRANGE, R. C., STUCKER, I., SUGIMURA, H., GARTE, S., GASPARI, L. and TAIOLI, E.

, CYP

A

T

C polymorphism and lung cancer: a pooled analysis of

cases and

controls. International Journal of Cancer,

,

(cid:

)

/ WANG-GOHRKE, S., WEIKEL, W., RISCH, H., VESPRINI, D., ABRAHAMSON, J., LERMAN, C., GODWIN, A., MOSLEHI, R., OLIPADE, O., BRUNET, J. S., STICKELER, E., KREIENBERG, R., WEBER, B., NAROD, S. A. and RUNNEBAUM, I. B

, Intron variants of the p

gene are associated with increased risk for ovarian cancer but not in carriers of BRCA

or BRCA

germline mutations. British Journal of Cancer,

,

(cid:

)

/ WANG-GOHRKE, S., BECHER, H., KREIENBERG, R., RUNNEBAUM, I. B. and CHANG-CLOUDE, J.

, Intron

bp duplication polymorphism of p

is associated with an increase risk for breast cancer by the age of

years. Pharmacogenetics,

,

(cid:

)

/ WANI, M. A., ZHU, Q., EL-MAHDY, M., VENKATACHALAM, S. and WANI, A. A.

, Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p

function in human cells. Cancer Research,

,

(cid:

) /

JOHNSON, T. E. 1997, Genetic influences on aging. Experimental Gerontology, 32, 11(cid:1) /22. KINZLER, K. W. and VOGELSTEIN, B. 1997, Cancer-susceptibility genes. Gatekeepers and

LAW, J. C., STRONG, L. C., CHIDAMBARAM, A. and FERRELL, R. E. 1991, Germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Research, 51, 6385(cid:1)6387. / LAZAR, V., HAZARD, F., BERTIN, F., JANIN, N., BELLET, D. and BRESSAC, B. 1993, Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703(cid:1)1705. / LEROI, A. M., KOUFOPANOU, V. and BURT, A. 2003, Cancer selection. Nature Reviews, Cancer, 3, 226(cid:1) /

P., VEGLIA, F., BENHAMOU, S., BUTKIEWICZ, D., CASCORBI, I., CLAPPER, M. L., DOLZAN, V., HAUGEN, A., HIRVONEN, A., INGELMAN-SUNDBERG, M., KIHARA, M., KIYOHARA, C., KREMERS, P., LE MARCHAND, L., OHSHIMA, S., PASTORELLI, R., RANNUG, A., ROMKES, M., SCHOKET, B., SHIELDS, P., STRANGE, R. C., STUCKER, I., SUGIMURA, H., GARTE, S., GASPARI, L. and TAIOLI, E. 2003, CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and /

M. A., ZHU, Q., EL-MAHDY, M., VENKATACHALAM, S. and WANI, A. A. 2000, Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Research, 60, 2273(cid:1) /